A Novel Probe for Spliceosomal Proteins that Induces Autophagy and Death of Melanoma Cells Reveals New Targets for Melanoma Drug Discovery

BACKGROUND/AIMS: Despite recent advances in melanoma drug discovery, the average overall survival of patients with late stage metastatic melanoma is approximately 3 years, suggesting a need for approaches that identify new melanoma targets. We have previously reported a discovery of novel anti-melan...

Descripción completa

Detalles Bibliográficos
Autores principales: Palrasu, Manikandan, Knapinska, Anna M., Diez, Juan, Smith, Lyndsay, LaVoi, Travis, Giulianotti, Marc, Houghten, Richard A., Fields, Gregg B., Minond, Dmitriy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990463/
https://www.ncbi.nlm.nih.gov/pubmed/31573152
http://dx.doi.org/10.33594/000000164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990463/
https://www.ncbi.nlm.nih.gov/pubmed/31573152
http://dx.doi.org/10.33594/000000164

Ejemplares similares